Loading…
Loading…
Biocorrx Inc. (OTCMKTS:BICX - Get Free Report) was the target of a large decline in short interest in July. As of July 31st, there was short interest totaling 543 shares, a decline of 68.8% from the July 15th total of 1,741 shares. Approximately 0.0% of the shares of the stock are short sold. Based on
Biocorrx Inc. (OTCMKTS:BICX - Get Free Report) was the recipient of a large increase in short interest in the month of July. As of July 15th, there was short interest totaling 1,741 shares, an increase of ∞ from the June 30th total of 0 shares. Based on an average daily volume of 3,240 shares, the
IceCure Medical (NASDAQ: ICCM - Get Free Report) and Biocorrx (OTCMKTS:BICX - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, valuation, profitability, risk, dividends, earnings and institutional ownership. Risk and Volatility IceCure Medical has a beta
Biocorrx (OTCMKTS:BICX - Get Free Report) and GoodRx (NASDAQ: GDRX - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability. Profitability This table compares Biocorrx and GoodRx's net margins,
Biocorrx Inc. (OTCMKTS:BICX - Get Free Report)'s share price crossed above its 50 day moving average during trading on Wednesday. The stock has a 50 day moving average of $0.32 and traded as high as $0.3995. Biocorrx shares last traded at $0.3995, with a volume of 4,789 shares. Biocorrx Stock Performance The company's 50
Biocorrx Inc. (OTCMKTS:BICX - Get Free Report)'s share price crossed below its 50 day moving average during trading on Monday. The stock has a 50 day moving average of $0.38 and traded as low as $0.2725. Biocorrx shares last traded at $0.2725, with a volume of 350 shares changing hands. Analyst Ratings Changes Separately,
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
Biocorrx (OTCMKTS:BICX - Get Free Report) and CVS Health (NYSE: CVS - Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, risk, valuation and profitability. Profitability This table compares Biocorrx and CVS Health's net